All data are based on the daily closing price as of October 8, 2025
s

Sysmex

6869.TSE
12.62 USD
-0.05
-0.39%

Overview

Last close
12.62 usd
Market cap
7.87B usd
52 week high
21.25 usd
52 week low
12.10 usd
Target price
18.01 usd

Valuation

P/E
22.0123
Forward P/E
27.933
Price/Sales
2.3527
Price/Book Value
2.4115
Enterprise Value
7.22B usd
EV/Revenue
2.1673
EV/EBITDA
9.053

Key financials

Revenue TTM
3.29B usd
Gross Profit TTM
1.74B usd
EBITDA TTM
816.20M usd
Earnings per Share
0.56 usd
Dividend
0.21 usd
Total assets
4.44B usd
Net debt
-69.39M usd

About

Sysmex Corporation engages in the development, manufacture, and sale of diagnostic instruments, reagents, and related software. It offers non-clinical blood testing and cell analysis for hematology, such as XN-V series, a software for laboratory animal corresponding to XN series fully automated hematology analyzers; XN-Series, a fully automated flagship hematology analyzers; and Automated hematology analyzer ProCyte Dx for Research applications, a housed in a compact body that simultaneously measures five types of leukocytes and reticulocyte counts; coagulation, blood gas/ electrolyte/ urinalysis, cells/ microorganisms, including particle counter/analyzer CDA-1000/1000B, an equipment which is capable of counting cells, yeast, algae, bacteria, and others. The company serves national and other public hospitals, general hospitals, universities, research institutes, other medical institutions, etc. The company was formerly known as TOA Medical Electronics Co., Ltd. and changed its name to Sysmex Corporation in October 1998. Sysmex Corporation was founded in 1968 and is headquartered in Kobe, Japan.
  • Symbol
    6869.TSE
  • Exchange
    TSE
  • Isin
    JP3351100007
  • Country
    Japan
  • Sector
    Healthcare
  • Industry
    Medical Devices
  • CEO
    Mr. Hisashi Ietsugu
  • Headquarter
    Kobe
  • Web site
    https://www.sysmex.co.jp
Jakota Newsletter

Stay ahead in the JAKOTA stock markets with our roundup of vital insights

Icon scroll to top